1. Home
  2. GWH vs ENSC Comparison

GWH vs ENSC Comparison

Compare GWH & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ESS Tech Inc.

GWH

ESS Tech Inc.

HOLD

Current Price

$0.19

Market Cap

8.5M

Sector

Miscellaneous

ML Signal

HOLD

Logo Ensysce Biosciences Inc.

ENSC

Ensysce Biosciences Inc.

HOLD

Current Price

$0.42

Market Cap

7.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GWH
ENSC
Founded
2011
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5M
7.6M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
GWH
ENSC
Price
$0.19
$0.42
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $2.25
N/A
AVG Volume (30 Days)
★ 1.1M
475.7K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
40.71
★ 65.24
EPS
N/A
★ N/A
Revenue
$1,583,000.00
★ $5,066,650.00
Revenue This Year
$33.99
$55.01
Revenue Next Year
$1,328.57
$1,033.97
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.17
$0.23
52 Week High
$13.87
$2.75

Technical Indicators

Market Signals
Indicator
GWH
ENSC
Relative Strength Index (RSI) 26.68 47.76
Support Level N/A $0.40
Resistance Level $0.42 $0.44
Average True Range (ATR) 0.04 0.03
MACD -0.01 -0.01
Stochastic Oscillator 7.23 10.89

Price Performance

Historical Comparison
GWH
ENSC

About GWH ESS Tech Inc.

ESS Tech Inc is a long-duration energy storage company specializing in iron flow battery technology. It develops and manufactures long-duration energy storage systems based on iron flow battery technology. The company's batteries use earth-abundant materials, including iron, salt, and water, and are designed for high cycle life and recyclability. It operates as a single business operating segment, which includes all activities related to the design, engineering, and manufacturing of the company's long duration energy storage products. The company's revenue is derived from the sale of its energy storage products and from service contracts.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: